|
US2013211227A1
|
|
Method and system for differential diagnosis of chronic schizophrenia and chronic alcoholism
|
|
US2010010336A1
|
|
Method and system for diagnosis of neuropsychiatric disorders including attention deficit hyperactivity disorder (adhd), autism, and schizophrenia
|
|
US2009069423A1
|
|
Compounds, compositions and methods for producing antioxidants from carnitine
|
|
US2008292557A1
|
|
Compounds, compositions and methods for medical imaging of Parkinson's disease
|
|
US2006257842A1
|
|
Cryopreservation media and molecules
|
|
US2006292547A1
|
|
Method and system for diagnosis of neuropsychiatric disorders including chronic alcoholism
|
|
US2006088614A1
|
|
Compounds, compositions and methods for treating neuropsychiatric disorders
|
|
US2005272812A1
|
|
Methor for use of acetyl-L-carnitine (ALCAR) for treatment of depressive disorders in humans
|
|
CN1795198A
|
|
Glycerophosphocholine and its derivatives for medical imaging of neuropsychiatric disorders
|
